Advanced Biomed Inc. (ADVB) vs DermTech, Inc. (DMTKQ)

Advanced Biomed Inc. and DermTech, Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. and DermTech, Inc. are of similar size ($3.3M and $3.1M). DermTech, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.3×. Advanced Biomed Inc. has the higher net margin (0.00% vs −572.2%) and the higher return on invested capital (−33.4% vs −5,493.5%). Across the 12 metrics below, Advanced Biomed Inc. leads on 11 and DermTech, Inc. on 1.

Valuation

Metric ADVB DMTKQ Diagnostics & Research median
P/E 0.33 n/m 34.52
P/S n/m n/m 4.24
P/B 0.20 n/m 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m 0.45 23.44
EV/Sales n/m (2.49) 5.18
Earnings yield 300.76% 0.00% (1.50%)
Free cash flow yield (185.35%) 0.00% 0.00%

Profitability

Metric ADVB DMTKQ Diagnostics & Research median
Gross margin — 8.51% 48.32%
Operating margin 0.00% (588.62%) (5.68%)
Net margin 0.00% (572.19%) (4.10%)
Free cash flow margin 0.00% (460.10%) 0.00%
Return on equity 84.77% (121.75%) 0.00%
Return on assets 36.47% (64.00%) (6.05%)
Return on invested capital (33.43%) (5,493.45%) 0.00%

Growth

Metric ADVB DMTKQ Diagnostics & Research median
Revenue growth (TTM) — 9.71% 8.99%
EPS growth (last fiscal year) 266.56% 20.36% 20.36%
Revenue growth, 5-year CAGR — 44.33% 7.30%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB DMTKQ Diagnostics & Research median
Debt to equity 0.00 0.00 0.01
Current ratio 9.33 3.53 2.27
Net debt to EBITDA 0.06 0.57 0.68

Dividend

Metric ADVB DMTKQ Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric ADVB DMTKQ Diagnostics & Research median
Market cap 3.14m 3.29m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack